CorMedix
CRMD
5 hedge funds and large institutions have $1.13M invested in CorMedix in 2013 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, reducing their positions, and 3 closing their positions.
16% more capital invested
Capital invested by funds: $971K → $1.13M (+$159K)
0.19% more ownership
Funds ownership: 1.53% → 1.72% (+0.19%)
29% less funds holding
Funds holding: 7 → 5 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$251K |
| 2 |
U
UBS
Zurich,
Switzerland
|
+$5.99K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$4.38K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
-$59K |
CRMD Hedge Fund Activity: Q3 2013 in Review
5 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q3 2013, worth a combined $1.13M — up 16% from $971K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CRMD and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 2 added.
The largest buyer was Millennium Management, adding an estimated $251K. The largest seller was AQR Capital Management, exiting entirely with an estimated $59K sold.
- 5 institutional investors held CorMedix (CRMD) as of Q3 2013, down from 7 in Q2 2013.
- Funds reported $1.13M of CorMedix stock for Q3 2013, up 16% quarter-over-quarter.
- 1 fund opened new CorMedix positions in Q3 2013 and 3 closed out, a net change of -2 holders.
- The largest CorMedix buyer in Q3 2013 was Millennium Management, an estimated $251K added.
- The largest CorMedix seller in Q3 2013 was AQR Capital Management, an estimated $59K sold.
Based on aggregated 13F filings for Q3 2013.